We are live on
!
Find out more
SAM
Strategy Asset Managers Portfolio holdings
AUM
$650M
Turnover
21.36%
1-Year Est. Return
25.51%
This Fund
S&P 500
This Quarter
Est. Return
+10.22%
1 Year Est. Return
+25.51%
3 Year Est. Return
+115.5%
5 Year Est. Return
+130.94%
10 Year Est. Return
+375.79%
AUM
$422M
AUM Growth
+$39.5M
(+10%)
Cap. Flow
+$5.79M
Cap. Flow
% of AUM
1.37%
Top 10 Holdings %
Top 10 Hldgs %
29.7%
Holding
240
New
12
Increased
81
Reduced
118
Closed
12
Avg Time Held
2.7
years
Top 10 Avg Time Held
3.5
years
Top 20 Avg Time Held
4.4
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$5.19M |
| 2 |
UnitedHealth
UNH
|
+$3.72M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.97M |
| 4 |
Dick's Sporting Goods
DKS
|
+$2.42M |
| 5 |
Air Products & Chemicals
APD
|
+$1.99M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$5.51M |
| 2 |
iShares US Medical Devices ETF
IHI
|
+$1.04M |
| 3 |
Medtronic
MDT
|
+$945K |
| 4 |
iShares Core US Aggregate Bond ETF
AGG
|
+$672K |
| 5 |
Corning
GLW
|
+$633K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.31% |
| 2 | Miscellaneous | 14.94% |
| 3 | Industrials | 12.36% |
| 4 | Healthcare | 11.57% |
| 5 | Financials | 10.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
226
Indaptus Therapeutics
INDP
$380M
| $79.8K | 0.02% |
1,619
| – | – |
2022 Q3
5 quarters
|
|
227
Dakota Gold
DC
$741M
| $64.2K | 0.02% |
24,500
-5,500
| -18% | -$14.8K |
2022 Q3
5 quarters
|
|
228
Northern Dynasty Minerals
NAK
$515M
| $11.3K | ﹤0.01% |
35,000
| – | – |
2023 Q3
1 quarter
|
|
|
229
iShares Core US Aggregate Bond ETF
AGG
$138B
| – | – |
-7,148
| Closed | -$672K | – |
|
230
Brown-Forman Class B
BF.B
$13.1B
| – | – |
-3,818
| Closed | -$220K | – |
|
231
Clorox
CLX
$10.4B
| – | – |
-1,841
| Closed | -$241K | – |
|
232
Emcor
EME
$32.3B
| – | – |
-953
| Closed | -$201K | – |
|
233
First Trust NYSE Arca Biotechnology Index Fund
FBT
$2.93B
| – | – |
-3,152
| Closed | -$461K | – |
|
|
234
iShares US Medical Devices ETF
IHI
$3.75B
| – | – |
-21,355
| Closed | -$1.04M | – |
|
235
KBR
KBR
$4.59B
| – | – |
-4,133
| Closed | -$244K | – |
|
236
McCormick & Company Non-Voting
MKC
$12.3B
| – | – |
-2,962
| Closed | -$224K | – |
|
237
RTX Corp
RTX
$252B
| – | – |
-4,280
| Closed | -$308K | – |
|
238
J.M. Smucker
SJM
$13.5B
| – | – |
-2,161
| Closed | -$266K | – |
|
239
iShares TIPS Bond ETF
TIP
$14.4B
| – | – |
-3,486
| Closed | -$362K | – |
|
240
T. Rowe Price
TROW
$21.6B
| – | – |
-2,050
| Closed | -$215K | – |
|
Similar funds
BI
GCM
GWAG
BRIM
PPW
OCAM
AAS
TAWM
Strategy Asset Managers's Q4 2023 Portfolio in Review
As of Q4 2023, Strategy Asset Managers held 240 positions worth $422M, up 10% from $382M the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Strategy Asset Managers's Q4 2023 filing shows 12 new, 81 increased, 118 reduced and 12 closed positions. Its largest new stake was Dick's Sporting Goods: 19,908 shares worth $2.93M. The largest sale was Pfizer, an estimated $5.51M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 21% a quarter earlier, followed by Miscellaneous and Industrials.
- Strategy Asset Managers's largest Q4 2023 buy was Dick's Sporting Goods: 19,908 shares worth $2.93M.
- Strategy Asset Managers added most to Eli Lilly in Q4 2023, an estimated $5.19M increase.
- Strategy Asset Managers's biggest Q4 2023 reduction was Pfizer, cutting an estimated $5.51M.
- Strategy Asset Managers fully exited iShares US Medical Devices ETF in Q4 2023, selling an estimated $1.04M.
- Strategy Asset Managers's ten largest holdings make up 30% of its $422M portfolio in Q4 2023.
- Strategy Asset Managers opened 12 new positions and closed 12 in Q4 2023.
- Strategy Asset Managers's portfolio value rose 10% quarter-over-quarter to $422M.
Based on Strategy Asset Managers's 13F filing for Q4 2023, filed 12 Feb 2024.